11，Rossler R． Kloeden PE． Hoff A et al. Pitfalls and questions concerning the melationin anti-aging pill. In Proceedings of 2ndLocarno meeting on neuroendocrinoimmunity．199651
22，Tan DX． Poeggler B． Reiter R et al. The pineal hormone melatonin inhibits DNA-adduct formation induced by the chemicalsafrole in vivo. Cancer Lett．19937065～71
33，Pomero MP． Osuna C． Garcia A et al. The pineal secretory product melatonin reduces hydrogen peroxide-induced DNA da-mage in U-937 cells. J Pineal Res．199926（4):227～235
44，Vijayalaxmi． Reiter RJ． Meltz MZ et al. Melatonin possible me-chanisms involved in itsradioprotective effect. Mutat Res．1998404（1-2L187～189
55，Ling X． Zhang LM． Lu SD et al. Over-expression of bcl-2 isassociated with protection of melatonin in neuronal injury fo-llowing a transient middle cerebral artery occusion inrats.ActaPharmacol Sin． 199920in press
66，Ross AW． Barrett P． Mercer JG et al. Melatonin suppress theinduction of AP-1 trsnscription factor components in the parstuberalis of the pituitary. Mol Cell Endocrinol．1996123（1):71～80
77，Gutteridge JMC. Hydroxyl radicals． iron． oxidative stress． andneurodegeneration. Ann NY Acad Sci．1994738201～213
88，Reiter RJ． Melchiorri D． Seweerynek E et al. A review of theevidence supporting melatonin＇s role as an antioxidant. J Pin-el Res． 199518（1):1～11
99，Tan DX． Chen LD． Poeggeler B et al. Melatonina potent en-dogenous hydroxyl radical scavenger. Endocrine J． 1993157～60
1010，Xue-Jun Li． Jing Gu． Bai-Shen Pan et al. Effect of melato-nin on production of hydroxyl radical and lactata dehydroge-nase during hypoxia in rat cortical slice. Acta Pharmacol sin．199920（3):201～205
